Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Nature Communications|February 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancerKatsuhiro Ito, Kei Iida, Tomoko Hirano, et al.
Interactive Cardiovascular and Thoracic Surgery|August 24, 2018
Low incidence of and mortality from a second malignancy after resection of thymic carcinoma†Masatsugu Hamaji, Atsushi Kawaguchi, Mitsugu Omasa, et al.
EMBO Reports|November 7, 2022
ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressivenessSho Koyasu, Shoichiro Horita, Keisuke Saito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2020
Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206Hirotsugu Kenmotsu, Seiji Niho, Masahiro Tsuboi, et al.
Cancer Science|April 9, 2025
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin DownregulationKazutaka Hosoya, Hiroaki Ozasa, Hironori Yoshida, et al.
Surgery Today|November 16, 2018
Survival outcomes after minimally invasive thymectomy for early-stage thymic carcinomaRyo Miyata, Masatsugu Hamaji, Mitsugu Omasa, et al.
Pageof 13